Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 3/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.46 |
| ▸ | CTSS | P25774 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.44 |
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.42 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7464405 | 1.00 | SLC7A5 (0.57) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL594571 | 1.00 | SLC7A5 (0.57) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL27704336 | 0.98 | SLC7A5 (0.56) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL4422991 | 0.98 | SLC7A5 (0.56) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL7687022 | 0.98 | SLC7A5 (0.56) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL7395431 | 0.88 | ACACB (0.44) | SLC7A5ESR1ESR2CTSSCTSK | |
| SCHEMBL6666822 | 0.87 | SLC7A5 (0.45) | SLC7A5 | |
| SCHEMBL3203564 | 0.87 | SLC7A5 (0.45) | SLC7A5 | |
| SCHEMBL17978113 | 0.87 | SLC7A5 (0.45) | SLC7A5 | |
| SCHEMBL17978114 | 0.87 | SLC7A5 (0.45) | SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119470406-A | Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof | 山东新华莎罗雅生物技术有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-114907546-A | Multifunctional polyurea acid ester derivative and preparation method and application thereof | 四川大学 | 2022-08-16 | — | — | CN | claimed |
| CN-114716635-A | Multifunctional polyurea-amino acid derivative and preparation method and application thereof | 四川大学 | 2022-07-08 | — | — | CN | claimed |
| CN-102320950-B | Method for synthesizing acetic acid through carbonylation | SHANGHAI HUAYI GROUP CO | 2015-05-13 | — | — | CN | claimed |
| CN-101659607-B | Method for preparing acetic acid and acetic anhydride respectively or synchronously | SHANGHAI COKING & CHEM CORP | 2013-04-10 | — | — | CN | claimed |
| CN-101927201-B | Method for removing impurities from solution of acetic acid and/or acetic anhydride hydroformylation catalyst | SHANGHAI COKING & CHEM CORP | 2012-12-12 | — | — | CN | claimed |
| CN-102320950-A | Method for synthesizing acetic acid through carbonylation | SHANGHAI HUAYI GROUP CO | 2012-01-18 | — | — | CN | claimed |
| CN-101658800-B | Catalyst system for use in preparation of acetic acid and acetic anhydride or synchronous preparation of acetic acid and acetic anhydride and preparation method thereof | SHANGHAI COKING & CHEM CORP | 2011-11-02 | — | — | CN | claimed |
| CN-101927201-A | Method for removing impurities from solution of acetic acid and/or acetic anhydride hydroformylation catalyst | SHANGHAI COKING & CHEM CORP | 2010-12-29 | — | — | CN | claimed |
| CN-101658800-A | Catalyst system for use in preparation of acetic acid and acetic anhydride or synchronous preparation of acetic acid and acetic anhydride and preparation method thereof | SHANGHAI COKING & CHEMICAL COR | 2010-03-03 | — | — | CN | claimed |
| CN-101659607-A | Method for preparing acetic acid and acetic anhydride respectively or synchronously | SHANGHAI COKING & CHEMICAL COR | 2010-03-03 | — | — | CN | claimed |
| EP-1051195-A4 | IDENTIFICATION OF AGENTS THAT PROTECT AGAINST INFLAMMATORY INJURY TO NEURONS | BAYLOR COLLEGE MEDICINE (US) | 2004-06-09 | — | — | EP | claimed |
| EP-1051195-A1 | IDENTIFICATION OF AGENTS THAT PROTECT AGAINST INFLAMMATORY INJURY TO NEURONS | BAYLOR COLLEGE OF MEDICINE (US) | 2000-11-15 | — | — | EP | claimed |
| WO-1998011923-A1 | IDENTIFICATION OF AGENTS THAT PROTECT AGAINST INFLAMMATORY INJURY TO NEURONS | BAYLOR COLLEGE OF MEDICINE (US) | 1998-03-26 | — | — | WO | claimed |
| US-12162902-B2 | Decarboxylase inhibitors for treating Parkinson's disease | SAIL BIOMEDICINES (US) | 2024-12-10 | — | — | US | disclosed |
| WO-2024107014-A1 | ANTI-BASAL CELL ADHESION MOLECULE ANTIBODY-DRUG CONJUGATE | GENOME AND COMPANY (KR) | 2024-05-23 | — | — | WO | disclosed |
| US-20240101642-A1 | SYSTEM AND METHOD FOR HOMOGENOUS GPCR PHOSPHORYLATION AND IDENTIFICATION OF BETA-2 ADRENERGIC RECEPTOR POSITIVE ALLOSTERIC MODULATORS | DUKE UNIVERSITY | 2024-03-28 | — | — | US | disclosed |
| US-4595700-A | Thiol based collagenase inhibitors | G. D. SEARLE & CO. (US) | 1986-06-17 | — | — | US | disclosed |
| EP-0086053-B1 | PROCESS FOR SYNTHESIZING PEPTIDES OR PEPTIDE DERIVATIVES | Imahori, Kazutomo (JP) | 1986-01-02 | — | — | EP | disclosed |
| US-4276288-A | Dehydrooligopeptides, their production and their medicinal use | TROPONWERKE GMBH & CO., KG (DE) | 1981-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240101642-A1 | SYSTEM AND METHOD FOR HOMOGENOUS GPCR PHOSPHORYLATION AND IDENTIFICATION OF BETA-2 ADRENERGIC RECEPTOR POSITIVE ALLOSTERIC MODULATORS | ADRB2, ARRB1, ADRB1 | SLC7A5 4655/4885TAAR1 568/4885SLC6A2 1616/4885 |
| US-12162902-B2 | Decarboxylase inhibitors for treating Parkinson's disease | DDC, DDT, DDO | SLC7A5 966/4885TAAR1 2261/4885SLC6A2 743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.